Eradivir

Eradivir is a preclinical biotechnology company developing antiviral therapeutic drugs. The company aims to harness the power of the immune system to treat diseases. Its small-molecule bispecific immunotherapy can specifically bind patients' immune cells to diseased cells, promoting the rapid and selective destruction of the diseased cells.